VolitionRX Limited VNRX
0.26
0.01
4.00%
as of 25 Sep
- Market cap
- $6.9M
- P/E
- 0.0×
Follow VNRX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 76.95% | 78.86% | 75.71% | 78.10% |
+8 more TTM periods Free account |
|
| (301.54%) | (280.21%) | (286.58%) | (239.21%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
439.37% | 465.89% | 380.28% | 391.35% | |
Average Days of Receivables |
41.19 | 37.33 | 67.15 | 76.64 | |
Free Cash Flow per Share |
(2.14) | (3.02) | (3.70) | (3.65) | |
Free Cash Flow |
(19.58) | (20.76) | (19.77) | (19.77) | |
Capital Expenditures |
(0.02) | (0.10) | (0.09) | (0.15) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
99.03% | 108.38% | 83.43% | 78.02% | |
Accounts Receivable Turnover |
10.53 | 11.21 | 8.06 | 4.74 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
382.68% | 418.72% | 583.61% | 692.95% | |
Selling, General and Administrative Expense of Revenue |
507.52% | 555.76% | 774.85% | 949.19% | |
Share Based Compensation of Revenue |
38.21% | 61.36% | 100.71% | 149.33% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.84 | 0.84 | 0.86 | |
Depreciation/Fixed assets |
0.94 | 0.89 | 0.73 | 0.50 | |
Capex/Depreciation |
(0.01) | (0.03) | (0.03) | (0.07) | |
Revenue per Share |
0.27 | 0.36 | 0.32 | 0.27 | |
Operating CF per Share |
(2.14) | (3.00) | (3.68) | (3.63) | |
Capex per Share |
0.00 | (0.01) | (0.02) | (0.03) | |
Capex to Sales |
0.01 | 0.04 | 0.05 | 0.10 | |
Net Profit Margin |
(1,043.08%) | (997.45%) | (1,352.15%) | (1,554.22%) |
Columns are period end dates